STUDIES OF PHAGOCYTOSIS OF GROUP A STREPTOCOCCI BY POLYMORPHONUCLEAR LEUCOCYTES IN VITRO

Studies have been made on phagocytosis and killing of Group A streptococci during mixing with suspensions of leucocytes in vitro. Under appropriate test conditions an anti-phagocytic effect can be demonstrated for the streptococcal hyaluronic acid capsule as well as for its M protein. The results obtained suggest an explanation for the suitability of human, but not rabbit, blood for opsonophagocytic tests designed to measure type-specific streptococcal antibodies. Human sera contain a factor which counteracts the anti-phagocytic effects of streptococcal hyaluronic acid capsules, and hence human blood serves well for detection of antibodies which combine with the only other phagocytosis-resisting component of this microorganism, namely M protein. In contrast, rabbit sera contain none of this factor, and addition of antibody to M protein to phagocytic test systems employing rabbit serum does not necessarily render the streptococci susceptible to engulfment by white cells, since the hyaluronic acid capsule may continue to interfere with phagocytosis. The nature of the human serum factor which opsonizes encapsulated streptococci is unknown. It does not appear to be an antibody or an enzyme capable of depolymerizing hyaluronic acid.

[1]  Mary R. Smith,et al.  STUDIES ON THE PATHOGENICITY OF GROUP A STREPTOCOCCI , 1959, The Journal of experimental medicine.

[2]  G. G. Wiley The lack of bactericidal effect of mouse blood for nonvirulent group A streptococci. , 1959, Journal of immunology.

[3]  G. Stollerman,et al.  ACCESSORY PLASMA FACTORS INVOLVED IN THE BACTERICIDAL TEST FOR TYPE-SPECIFIC ANTIBODY TO GROUP A STREPTOCOCCI , 1958, The Journal of experimental medicine.

[4]  Armine T. Wilson,et al.  FATE OF NON-VIRULENT GROUP A STREPTOCOCCI PHAGOCYTIZED BY HUMAN AND MOUSE NEUTROPHILS , 1957, The Journal of experimental medicine.

[5]  Fleck Dg Mouse protection and enhancement of phagocytosis by antisera to Streptococcus pyogenes. , 1956 .

[6]  J. G. Hirsch PHAGOCYTIN: A BACTERICIDAL SUBSTANCE FROM POLYMORPHONUCLEAR LEUCOCYTES , 1956, The Journal of experimental medicine.

[7]  C. V. Seastone,et al.  THE RELATIONSHIP OF M PROTEIN AND RESISTANCE TO PHAGOCYTOSIS IN THE BETA HEMOLYTIC STREPTOCOCCI , 1955, Journal of bacteriology.

[8]  S. Rothbard BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI , 1945, The Journal of experimental medicine.

[9]  A. Kuttner,et al.  THE OCCURRENCE OF BACTERIOSTATIC PROPERTIES IN THE BLOOD OF PATIENTS AFTER RECOVERY FROM STREPTOCOCCAL PHARYNGITIS. , 1944, The Journal of clinical investigation.

[10]  E. Kass,et al.  THE RÔLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI , 1944, The Journal of experimental medicine.

[11]  W. R. Maxted,et al.  Factors which determine the fate of hæmolytic streptococci (group A) in shed blood and in serum , 1939 .

[12]  D. Fleck Mouse protection and enhancement of phagocytosis by antisera to Streptococcus pyogenes. , 1956, British journal of experimental pathology.